Abstract

High-dose ibuprofen—updated advice ● Risk management of new insulin products ● Mindfulness-based cognitive therapy ● Revised recommendations on administering live vaccines ● GI bleeding risk with dabigatran and ▼rivaroxaban ● Digoxin linked to increased mortality risk? ● More on faecal microbiota transplantation ● Review of treatments for hirsutism ● MHRA restricts use of hydroxyzine